Last Updated: November 13, 2026

TRIMOX Drug Patent Profile

Name: TRIMOX Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Trimox, and when can generic versions of Trimox launch?

Trimox is a drug marketed by Apothecon and is included in eight NDAs.

The generic ingredient in TRIMOX is amoxicillin. There is one drug master file entry for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Trimox

A generic version of TRIMOX was approved as amoxicillin by CHARTWELL RX on December 22^nd, 1992.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for TRIMOX?
What are the global sales for TRIMOX?
What is Average Wholesale Price for TRIMOX?

Summary for TRIMOX

US Patents:	0
Applicants:	1
NDAs:	8
Raw Ingredient (Bulk) Api Vendors:	61
Clinical Trials:	1
Patent Applications:	1,995
DailyMed Link:	TRIMOX at DailyMed

Drug patent expirations by year for TRIMOX

Recent Clinical Trials for TRIMOX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Nationwide Children's Hospital	N/A

See all TRIMOX clinical trials

US Patents and Regulatory Information for TRIMOX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	TRIMOX	amoxicillin	CAPSULE;ORAL	061885-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Apothecon	TRIMOX	amoxicillin	CAPSULE;ORAL	062152-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Apothecon	TRIMOX	amoxicillin	CAPSULE;ORAL	063099-001	Mar 20, 1992		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.